109 related articles for article (PubMed ID: 10965958)
1. Hepatitis B immune globulin: the US experience.
Pruett TL; McGory R
Clin Transplant; 2000; 14 Suppl 2():7-13. PubMed ID: 10965958
[TBL] [Abstract][Full Text] [Related]
2. Management of hepatitis B virus infection in liver transplant recipients: prospects and challenges.
Terrault N
Clin Transplant; 2000; 14 Suppl 2():39-43. PubMed ID: 10965963
[TBL] [Abstract][Full Text] [Related]
3. An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy.
Han SH; Ofman J; Holt C; King K; Kunder G; Chen P; Dawson S; Goldstein L; Yersiz H; Farmer DG; Ghobrial RM; Busuttil RW; Martin P
Liver Transpl; 2000 Nov; 6(6):741-8. PubMed ID: 11084061
[TBL] [Abstract][Full Text] [Related]
4. Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B.
Angus PW; McCaughan GW; Gane EJ; Crawford DH; Harley H
Liver Transpl; 2000 Jul; 6(4):429-33. PubMed ID: 10915163
[TBL] [Abstract][Full Text] [Related]
5. Evolving strategies to prevent HBV recurrence.
Roche B; Samuel D
Liver Transpl; 2004 Oct; 10(10 Suppl 2):S74-85. PubMed ID: 15382222
[TBL] [Abstract][Full Text] [Related]
6. Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin.
Markowitz JS; Martin P; Conrad AJ; Markmann JF; Seu P; Yersiz H; Goss JA; Schmidt P; Pakrasi A; Artinian L; Murray NG; Imagawa DK; Holt C; Goldstein LI; Stribling R; Busuttil RW
Hepatology; 1998 Aug; 28(2):585-9. PubMed ID: 9696028
[TBL] [Abstract][Full Text] [Related]
7. Prevention of hepatitis B recurrence after liver transplantation using lamivudine and hepatitis B immune globulin.
Ołdakowska-Jedynak U; Paczek L; Foroncewicz B; Mucha K; Nyckowski P; Zieniewicz K; Ziarkiewicz-Wróblewska B; Ziółkowski J; Pilecki T; Patkowski W; Górnicka B; Paczkowska A; Krawczyk M
Ann Transplant; 2007; 12(3):28-32. PubMed ID: 18290567
[TBL] [Abstract][Full Text] [Related]
8. Liver transplantation for hepatitis B cirrhosis: clinical sequela of passive immunization.
al-Hemsi B; McGory RW; Shepard B; Ishitani MB; Stevenson WC; McCullough C; Pruett TL
Clin Transplant; 1996 Dec; 10(6 Pt 2):668-75. PubMed ID: 8996763
[TBL] [Abstract][Full Text] [Related]
9. Antiviral therapy to prevent and treat hepatitis B virus infection in hepatic allografts.
Perrillo RP
Clin Transplant; 2000; 14 Suppl 2():25-8. PubMed ID: 10965961
[TBL] [Abstract][Full Text] [Related]
10. European hepatitis B immunoglobulin trials: prevention of recurrent hepatitis B after liver transplantation.
Krüger M
Clin Transplant; 2000; 14 Suppl 2():14-9. PubMed ID: 10965959
[TBL] [Abstract][Full Text] [Related]
11. [Post-transplant prophylaxis of the recurrence of lamivudine-resistant YMDD mutant hepatitis B virus in liver recipients].
Yang Y; Yang Y; Zhang J; Yi HM; Lu MQ; Cai CJ; Li X; Jiang N; Xu C; Li H; Wang GS; Yi SH; Zhang JF; Jiang H; Yang Q; Chen GH
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1810-2. PubMed ID: 18971179
[TBL] [Abstract][Full Text] [Related]
12. Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors.
Prakoso E; Strasser SI; Koorey DJ; Verran D; McCaughan GW
Clin Transplant; 2006; 20(3):369-73. PubMed ID: 16824156
[TBL] [Abstract][Full Text] [Related]
13. Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation.
Dodson SF; de Vera ME; Bonham CA; Geller DA; Rakela J; Fung JJ
Liver Transpl; 2000 Jul; 6(4):434-9. PubMed ID: 10915164
[TBL] [Abstract][Full Text] [Related]
14. Low-dose intramuscular hepatitis B immune globulin and lamivudine for long-term prophylaxis of hepatitis B recurrence after liver transplantation.
Ferretti G; Merli M; Ginanni Corradini S; Callejon V; Tanzilli P; Masini A; Ferretti S; Iappelli M; Rossi M; Rivanera D; Lilli D; Mancini C; Attili A; Berloco P
Transplant Proc; 2004 Apr; 36(3):535-8. PubMed ID: 15110584
[TBL] [Abstract][Full Text] [Related]
15. Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation.
Tillmann HL; Trautwein C; Bock T; Böker KH; Jäckel E; Glowienka M; Oldhafer K; Bruns I; Gauthier J; Condreay LD; Raab HR; Manns MP
Hepatology; 1999 Jul; 30(1):244-56. PubMed ID: 10385663
[TBL] [Abstract][Full Text] [Related]
16. Pharmacoeconomic analysis of HBV liver transplant therapies.
McGory R
Clin Transplant; 2000; 14 Suppl 2():29-38. PubMed ID: 10965962
[TBL] [Abstract][Full Text] [Related]
17. Transplantation in the hepatitis B patient and current therapies to prevent recurrence.
Colquhoun SD; Belle SH; Samuel D; Pruett TL; Teperman LW
Semin Liver Dis; 2000; 20 Suppl 1():7-12. PubMed ID: 10895438
[TBL] [Abstract][Full Text] [Related]
18. Prevention of de novo hepatitis B infection after liver transplantation with allografts from hepatitis B core antibody positive donors.
Dodson SF
Clin Transplant; 2000; 14 Suppl 2():20-4. PubMed ID: 10965960
[TBL] [Abstract][Full Text] [Related]
19. [Prevention and treatment of hepatitis B virus reinfection after liver transplantation].
Liu J; Wu GC; Zhang ZT; Wu P; Zhang D; Sun MC; Gao DC; Wang Y; Jia JD; Wang BE
Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):976-9. PubMed ID: 16194352
[TBL] [Abstract][Full Text] [Related]
20. Prophylaxis of hepatitis B virus recurrence after liver transplantation in carriers of lamivudine-resistant mutants.
Marzano A; Lampertico P; Mazzaferro V; Carenzi S; Vigano M; Romito R; Pulvirenti A; Franchello A; Colombo M; Salizzoni M; Rizzetto M
Liver Transpl; 2005 May; 11(5):532-8. PubMed ID: 15838891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
